News/ News/ Oncology GSK cancer head Hoos exits, takes top role at biotech Scorpion Phil Taylor GlaxoSmithKline, immuno-oncology, Oncology, Scorpion Therapeutics, senior management 0 Comment GlaxoSmithKline’s head of oncology Axel Hoos has resigned from the company, and will take up a new role Share X GSK cancer head Hoos exits, takes top role at biotech Scorpion https://pharmaphorum.com/news/gsk-cancer-head-hoos-exits-takes-top-role-at-biotech-scorpion/